Abstract
The authors regret that upon reviewing the final version, we identified an error in Figure 1, Page 4. The colour coding is incorrect and suggests a lack of consensus regarding bilobar liver metastases as oligometastatic disease, although consensus was in fact reached. • Current text: ≤ 3 unilobar liver metastases (consensus) ≤ 2 bilobar liver metastases (fair agreement).• Correction: ≤ 3 unilobar liver metastases (consensus) or ≤ 2 bilobar liver metastases (consensus).[Figure presented]The authors would like to apologise for any inconvenience caused.
| Original language | English |
|---|---|
| Article number | 100236 |
| Journal | ESMO Gastrointestinal Oncology |
| Volume | 11 |
| Early online date | 16 Sept 2025 |
| DOIs |
|
| Publication status | Published - Mar 2026 |
Fingerprint
Dive into the research topics of 'Corrigendum to ‘Oligometastatic disease in esophagogastric cancer: an update of recommendations on definition, diagnosis, and treatment’: [Volume 2 - Issue C – 2023 2949-8198] (ESMO Gastrointestinal Oncology (2023) 2, (S2949819823000092), (10.1016/j.esmogo.2023.08.008))'. Together they form a unique fingerprint.Research output
- 1 Review article
-
Oligometastatic disease in esophagogastric cancer: an update of recommendations on definition, diagnosis, and treatment
Kroese, T. E., Bronzwaer, S. F. C., van Hillegersberg, R., van Rossum, P. S. N. & van Laarhoven, H. W. M., Dec 2023, In: ESMO Gastrointestinal Oncology. 2, 100009.Research output: Contribution to journal › Review article › peer-review
Open AccessFile
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver